Global Conference on Liver & Hepatitis
Liver diseases contains wide scope of complex conditions influencing the liver. Liver sickness treatment advertise is guaranteed to develop by virtue of neglected clinical needs and up and coming treatment modifications. Many novel agents has shown improvements in clinical trials for example obeticholic acid, thiazolidinediones and vitamin E for treatment of nonalcoholic fatty liver diseases. In Addition, according to American Cancer Society liver cancer rates increases 2.7% every year propelling the growth of market. Based on treatment type the market is bifurcated into Chemotherapy drugs, targeted therapy, anti-viral drugs, immunoglobulins, corticosteroids, vaccines, anti-rejection drugs/immunosuppressant.